Global Artificial Intelligence (AI) in Life Sciences Market Research Report 2024

Publication ID:

PB511243538

Publication Date:

November 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Artificial intelligence(AI) in life sciences refers to the application of artificial intelligence technology to life science research and practice, and the improvement of the efficiency, accuracy and depth of life science research through computer simulation, big data analysis, machine learning, etc. This field covers a wide range of aspects, from the collection, processing and analysis of biological information to drug development, clinical and molecular diagnosis, clinical trials, etc.
The global Artificial Intelligence (AI) in Life Sciences market was valued at US$ 7850 million in 2023 and is anticipated to reach US$ 31570 million by 2030, witnessing a CAGR of 21.6% during the forecast period 2024-2030.
North American market for Artificial Intelligence (AI) in Life Sciences is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Intelligence (AI) in Life Sciences is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Artificial Intelligence (AI) in Life Sciences in Contract Research Organizations is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Artificial Intelligence (AI) in Life Sciences include Atomwise, BenevolentAI, Recursion, Roche, Enlitic, Fujifilm, Illumina, GE HealthCare, Philips, Medtronic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence (AI) in Life Sciences, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence (AI) in Life Sciences.
The Artificial Intelligence (AI) in Life Sciences market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence (AI) in Life Sciences market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence (AI) in Life Sciences companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Atomwise
BenevolentAI
Recursion
Roche
Enlitic
Fujifilm
Illumina
GE HealthCare
Philips
Medtronic
Microsoft
Siemens Healthineers
Segment by Type
Software
Services
Segment by Application
Contract Research Organizations
Research Centers and Academic Institutes
Pharmaceutical and Biotechnology Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Life Sciences company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Life Sciences Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Software
1.2.3 Services
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Life Sciences Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Contract Research Organizations
1.3.3 Research Centers and Academic Institutes
1.3.4 Pharmaceutical and Biotechnology Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Life Sciences Market Perspective (2019-2030)
2.2 Global Artificial Intelligence (AI) in Life Sciences Growth Trends by Region
2.2.1 Global Artificial Intelligence (AI) in Life Sciences Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence (AI) in Life Sciences Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence (AI) in Life Sciences Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence (AI) in Life Sciences Market Dynamics
2.3.1 Artificial Intelligence (AI) in Life Sciences Industry Trends
2.3.2 Artificial Intelligence (AI) in Life Sciences Market Drivers
2.3.3 Artificial Intelligence (AI) in Life Sciences Market Challenges
2.3.4 Artificial Intelligence (AI) in Life Sciences Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence (AI) in Life Sciences Players by Revenue
3.1.1 Global Top Artificial Intelligence (AI) in Life Sciences Players by Revenue (2019-2024)
3.1.2 Global Artificial Intelligence (AI) in Life Sciences Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence (AI) in Life Sciences Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Artificial Intelligence (AI) in Life Sciences Revenue
3.4 Global Artificial Intelligence (AI) in Life Sciences Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Life Sciences Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Life Sciences Revenue in 2023
3.5 Global Key Players of Artificial Intelligence (AI) in Life Sciences Head office and Area Served
3.6 Global Key Players of Artificial Intelligence (AI) in Life Sciences, Product and Application
3.7 Global Key Players of Artificial Intelligence (AI) in Life Sciences, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence (AI) in Life Sciences Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Life Sciences Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence (AI) in Life Sciences Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence (AI) in Life Sciences Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Life Sciences Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence (AI) in Life Sciences Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence (AI) in Life Sciences Market Size (2019-2030)
6.2 North America Artificial Intelligence (AI) in Life Sciences Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Intelligence (AI) in Life Sciences Market Size by Country (2019-2024)
6.4 North America Artificial Intelligence (AI) in Life Sciences Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence (AI) in Life Sciences Market Size (2019-2030)
7.2 Europe Artificial Intelligence (AI) in Life Sciences Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Intelligence (AI) in Life Sciences Market Size by Country (2019-2024)
7.4 Europe Artificial Intelligence (AI) in Life Sciences Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market Size (2019-2030)
8.2 Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence (AI) in Life Sciences Market Size (2019-2030)
9.2 Latin America Artificial Intelligence (AI) in Life Sciences Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Intelligence (AI) in Life Sciences Market Size by Country (2019-2024)
9.4 Latin America Artificial Intelligence (AI) in Life Sciences Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence (AI) in Life Sciences Market Size (2019-2030)
10.2 Middle East & Africa Artificial Intelligence (AI) in Life Sciences Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Intelligence (AI) in Life Sciences Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Intelligence (AI) in Life Sciences Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Atomwise
11.1.1 Atomwise Company Details
11.1.2 Atomwise Business Overview
11.1.3 Atomwise Artificial Intelligence (AI) in Life Sciences Introduction
11.1.4 Atomwise Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.1.5 Atomwise Recent Development
11.2 BenevolentAI
11.2.1 BenevolentAI Company Details
11.2.2 BenevolentAI Business Overview
11.2.3 BenevolentAI Artificial Intelligence (AI) in Life Sciences Introduction
11.2.4 BenevolentAI Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.2.5 BenevolentAI Recent Development
11.3 Recursion
11.3.1 Recursion Company Details
11.3.2 Recursion Business Overview
11.3.3 Recursion Artificial Intelligence (AI) in Life Sciences Introduction
11.3.4 Recursion Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.3.5 Recursion Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Artificial Intelligence (AI) in Life Sciences Introduction
11.4.4 Roche Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Enlitic
11.5.1 Enlitic Company Details
11.5.2 Enlitic Business Overview
11.5.3 Enlitic Artificial Intelligence (AI) in Life Sciences Introduction
11.5.4 Enlitic Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.5.5 Enlitic Recent Development
11.6 Fujifilm
11.6.1 Fujifilm Company Details
11.6.2 Fujifilm Business Overview
11.6.3 Fujifilm Artificial Intelligence (AI) in Life Sciences Introduction
11.6.4 Fujifilm Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.6.5 Fujifilm Recent Development
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Artificial Intelligence (AI) in Life Sciences Introduction
11.7.4 Illumina Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 GE HealthCare
11.8.1 GE HealthCare Company Details
11.8.2 GE HealthCare Business Overview
11.8.3 GE HealthCare Artificial Intelligence (AI) in Life Sciences Introduction
11.8.4 GE HealthCare Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.8.5 GE HealthCare Recent Development
11.9 Philips
11.9.1 Philips Company Details
11.9.2 Philips Business Overview
11.9.3 Philips Artificial Intelligence (AI) in Life Sciences Introduction
11.9.4 Philips Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.9.5 Philips Recent Development
11.10 Medtronic
11.10.1 Medtronic Company Details
11.10.2 Medtronic Business Overview
11.10.3 Medtronic Artificial Intelligence (AI) in Life Sciences Introduction
11.10.4 Medtronic Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.10.5 Medtronic Recent Development
11.11 Microsoft
11.11.1 Microsoft Company Details
11.11.2 Microsoft Business Overview
11.11.3 Microsoft Artificial Intelligence (AI) in Life Sciences Introduction
11.11.4 Microsoft Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.11.5 Microsoft Recent Development
11.12 Siemens Healthineers
11.12.1 Siemens Healthineers Company Details
11.12.2 Siemens Healthineers Business Overview
11.12.3 Siemens Healthineers Artificial Intelligence (AI) in Life Sciences Introduction
11.12.4 Siemens Healthineers Revenue in Artificial Intelligence (AI) in Life Sciences Business (2019-2024)
11.12.5 Siemens Healthineers Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Atomwise
BenevolentAI
Recursion
Roche
Enlitic
Fujifilm
Illumina
GE HealthCare
Philips
Medtronic
Microsoft
Siemens Healthineers

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂